Cleared Abbreviated

K090957 - BLACKROCK NEUROPORT BIOPOTENTIAL SIGNAL PROCESSING SYSTEM

K090957 is an FDA 510(k) clearance for BLACKROCK NEUROPORT BIOPOTENTIAL SIGNAL..., manufactured by I2s Micro Implantable Systems, LLC. The device is a Class 2 Neurology device with product code GWL cleared through the Abbreviated 510(k) pathway after a 52-day FDA review.

K090957 · I2s Micro Implantable Systems, LLC · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2009
Decision
52d
Days
Class 2
Risk

K090957 is an FDA 510(k) clearance for the BLACKROCK NEUROPORT BIOPOTENTIAL SIGNAL PROCESSING SYSTEM. Classified as Amplifier, Physiological Signal (product code GWL), Class II - Special Controls.

Submitted by I2s Micro Implantable Systems, LLC (Stoughton, US). The FDA issued a Cleared decision on May 28, 2009 after a review of 52 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1835 - the FDA neurology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all I2s Micro Implantable Systems, LLC devices

FDA 510(k) Submission Details - K090957

510(k) Number K090957 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 06, 2009
Decision Date May 28, 2009
Days to Decision 52 days
Submission Type Abbreviated
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
96d faster than avg
Panel avg: 148d · This submission: 52d
Pathway characteristics
Standards-based clearance path.

GWL Device Classification - Class 2, Special Controls

Product Code GWL Amplifier, Physiological Signal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1835
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWL Amplifier, Physiological Signal

All 21
Devices cleared under the same product code (GWL) and FDA review panel - the closest regulatory comparables to K090957.
Digital NeuroPort Biopotential Signal Processing System
K202174 · Blackrock Microsystems · Feb 2021
8-CH Electroencephalography Amplifier
K201747 · Hipposcreen Neurotech Corp. · Dec 2020
eego amplifiers
K172312 · Eemagine Medical Imaging Solutions GmbH · Mar 2018
NEUROMETRIX BIOAMPLIFIER
K083322 · Neurometrix, Inc. · May 2009
SINGLE AMPLIFIER FOR BOTOX
K051852 · Allergan, Inc. · Sep 2005
SENSOR AMPLIFIER
K972515 · Pro-Tech Services, Inc. · Oct 1997